Vesilute
What do these badges mean?
Evidence tier
- AHuman-validated — Human trials showing positive results and good safety.
- BAnimal-grade — No human trials yet, but solid animal/preclinical evidence of effect and safety.
- CAnecdotal — No human or animal trials — only anecdotal/observational reports.
- DInsufficient evidence — No or insufficient evidence (encyclopedia only — never recommended by the builder).
Safety light
- 🟢 Green — Only mild, manageable side effects; reasonable safety data.
- 🟡 Yellow — Needs active management, has a meaningful contraindication/interaction, or has thin long-term data.
- 🔴 Red — Risk of a hospital-level event — treat with serious caution.
Browse-only — not on the protocol builder's curated shortlist, so the builder won't recommend it.
What is it?
Vesilute is a Khavinson-school bioregulator, not a topical cosmetic. It came through the same source directory as the rest of the cosmetic-topical peptide cluster, but doesn’t actually belong to the cosmetic-skincare story.
What does it do in my body?
Vesilute is claimed to be a short peptide bioregulator that modulates gene expression in vascular endothelial cells, supporting vessel-wall integrity.
How can it help me?
- Where the science stands: Anecdotal: 0 studies, 0 human trials
The full evidence — every human, animal, and lab study, graded — is one tap away: use the See the deeper science → toggle at the top.
Is it dangerous? What are the side effects?
No adverse-effect data specific to Vesilute was captured in the source profile. Safety is graded pending, reflecting the limited independent evidence base for this specific compound.
Regulatory status: Not a cosmetic ingredient. Framed within the Khavinson organ-peptide line, which is preclinical/Russian-school research territory rather than a regulated cosmetic or an FDA-reviewed drug.
Typical dosing
Talk to your medical provider before starting any protocol. That said, here are the doses most people commonly use — shared for educational purposes so you can have an informed conversation. These peptides are sold for research use only and are not FDA-approved drugs, and this isn't medical advice.
No cosmetic/topical protocol applies. The source material captured here doesn’t include a standalone dosing protocol for Vesilute specifically; see the Khavinson bioregulator cluster for the general framework this peptide belongs to.
What should I avoid combining — and what's synergistic?
Vesilute doesn't have a dedicated stacking protocol in our notes — the interactions that matter most are in the safety section above. For how people combine it with other peptides, the deeper-science view has the full detail.
How can I buy this?
Vesilute is available from BioLongevity Labs — use code OHM-15 at BioLongevity for 15% off. As always, buy only from a source that publishes third-party Certificates of Analysis (COAs) confirming identity and >99% purity.
When you use my coupon code to buy peptides with these sellers, you enjoy a discount off retail price, and I make a small commission which helps me to continue to offer this peptide educational site to you for free. I only have affiliate relationships with peptide manufacturers that show evidence that their peptides are 100% manufactured in the US, 3rd party lab tested for purity, transparent COAs posted on their websites, and that have good customer service.
A Khavinson-school bioregulator, not a topical cosmetic — it shares this cluster’s source directory but belongs, by mechanism and origin, to the Russian organ-peptide family covered in the Khavinson bioregulator family.
| Class | Khavinson-school bioregulator — vascular peptide (not a topical cosmetic, despite sharing this cluster’s source directory) |
| Mechanism (one line) | Claimed to modulate gene expression in vascular endothelial cells, supporting vessel-wall integrity |
| Evidence base | Anecdotal: 0 studies, 0 human trials |
| Safety record | Safety: pending |
| Regulatory status | Folded into the Khavinson organ-peptide line for framing purposes; not a cosmetic ingredient |
What it is
Vesilute is a Khavinson-school bioregulator, not a topical cosmetic. It came through the same source directory as the rest of the cosmetic-topical peptide cluster, but doesn’t actually belong to the cosmetic-skincare story.
How it works
Vesilute is claimed to be a short peptide bioregulator that modulates gene expression in vascular endothelial cells, supporting vessel-wall integrity.
What the research shows
Public profile grade: Anecdotal — 0 studies, 0 human trials.
OHM’s internal 0035 categorization pass folds Vesilute into the Khavinson organ-peptide line (alongside Livagen, Ovagen, Pancragen, Prostamax, and the rest), all graded Tier D / pending / provisional, noting “Russian-school preclinical with NO meaningful Western or independent Russian human RCT data” and recommending a single framework article rather than separate pages.
Status: belongs to the Khavinson bioregulator cluster, not the cosmetic-topical cluster — documented here only because it shared the source directory this cluster was originally built from. See the Khavinson bioregulator family for the fuller framework treatment of this peptide family.
Real-world protocol
No cosmetic/topical protocol applies. The source material captured here doesn’t include a standalone dosing protocol for Vesilute specifically; see the Khavinson bioregulator cluster for the general framework this peptide belongs to.
Side effects & management
No adverse-effect data specific to Vesilute was captured in the source profile. Safety is graded pending, reflecting the limited independent evidence base for this specific compound.
Regulatory status
Not a cosmetic ingredient. Framed within the Khavinson organ-peptide line, which is preclinical/Russian-school research territory rather than a regulated cosmetic or an FDA-reviewed drug.
Sources
- (thepeptidelist.com directory, captured 2026-06-07) — profile grade: Anecdotal, 0 studies, 0 human trials.
- OHM tier/safety grading: Tier D / pending / provisional, folded into the Khavinson organ-peptide line.
- Migrated from
cosmetic-topical-peptides-cluster.md(2026-06-10 cluster build) as part of the cluster-to-standalone-article migration — the source explicitly flags this compound as belonging to the Khavinson bioregulator family, not the cosmetic-topical family.
Related: the Khavinson bioregulator family
Sources & references
- (thepeptidelist.com directory, captured 2026-06-07) — profile grade: Anecdotal, 0 studies, 0 human trials.
- OHM tier/safety grading: Tier D / pending / provisional, folded into the Khavinson organ-peptide line.
- Migrated from
cosmetic-topical-peptides-cluster.md(2026-06-10 cluster build) as part of the cluster-to-standalone-article migration — the source explicitly flags this compound as belonging to the Khavinson bioregulator family, not the cosmetic-topical family.
Related: the Khavinson bioregulator family